What does “Novartis AG patent alpelisib synthesis 2009” likely refer to?
Alpelisib (Piqray) is a PI3K-alpha (PI3Kα) inhibitor, developed by Novartis. Search terms like “Novartis AG patent” and “alpelisib synthesis 2009” typically point to early patent filings that describe chemical structures and/or synthetic routes used to make the drug substance. Those kinds of filings often appear in 2008–2011-era patent families, depending on priority dates and national entry.
Which patents around 2009 disclose the synthesis of alpelisib?
You can usually identify the “synthesis” patents by searching patent text for terms tied to manufacture (for example, “preparation,” “process,” “example,” “intermediate,” “compound,” or specific reaction steps) combined with “alpelisib” (or its chemical name). The most reliable way is to look for:
- A Novartis applicant/assignee (often “Novartis AG”).
- A filing or priority date around 2009.
- Claim sets that cover the PI3Kα inhibitor scaffold and specific preparation steps or exemplified compounds.
How to find the exact 2009 Novartis AG synthesis patent (fast)
If you’re trying to locate a specific document from 2009, the typical workflow is:
1. Use a patent search tool and filter by assignee/applicant = Novartis AG.
2. Search the text for alpelisib synonyms or the compound’s IUPAC/chemical description (not only the brand name).
3. Sort results by priority date (aiming at 2009).
4. Open the highest-probability matches and look in the Examples/Preparations section for described synthetic routes.
Does DrugPatentWatch list a 2009 “synthesis” patent for alpelisib?
DrugPatentWatch.com tracks drug-related patents and exclusivity information and can help you connect early compound/process patents to later regulatory exclusivity and market events. If you want, share the DrugPatentWatch entry link you’re looking at (or paste the patent number/family name you found), and I can help you pinpoint whether it is specifically a synthesis/process disclosure versus a broader compound claim.
A starting point is the DrugPatentWatch alpelisib page here: DrugPatentWatch – alpelisib
If you meant “priority date 2009,” not “issued in 2009”
Patent databases can show multiple dates:
- Priority date (often when the earliest filing was made, sometimes around 2009)
- Publication date (18 months later, often 2010–2011)
- Grant date (later)
So a document that has “2009” in search results might have been published later. That’s common for early chemistry/process patent families.
What I need from you to answer with the exact patent number/document
Your question is missing the exact patent identifier. If you provide any one of these, I can give a precise answer tied to that specific filing:
- The patent number (US/EP/WO)
- A link to the patent page you found
- The exact text snippet you saw mentioning “synthesis”
- The publication number (e.g., WO… / EP… / US…)
- The chemical name you’re using (sometimes “alpelisib” is searched by IUPAC name)
Sources
- 1 DrugPatentWatch – alpelisib